Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein in Acute Appendicitis in Pediatric Patients
- Conditions
- Appendicitis Acute
- Interventions
- Diagnostic Test: Blood specimen collectionDiagnostic Test: Saliva specimen collection
- Registration Number
- NCT05093660
- Lead Sponsor
- KBC Split
- Brief Summary
Acute appendicitis is a common and potentially serious medical condition which can be difficult to diagnose, especially in pediatric patients. To help recognize patients with acute appendicitis, number of laboratory and radiological test are used. Previous research has shown that Circulating Human Leucine-rich α-2-glycoprotein (LGR1) in the blood can be elevated in pediatric patients with acute appendicitis. The aim of this research is to analyse whether LGR1 levels in saliva can be used as a less invasive diagnostic method in pediatric patients with suspected acute appendicitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 90
- children with age from 5 do 17 with acute abdominal pain
- children with clinical signs of appendicitis
- previous diagnosis of chronic and/or malignant disease
- children which had previous abdominal surgery
- pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients without acute appendicitis Blood specimen collection Patients without acute appendicitis, after laboratory, clinical and/or radiological exclusion of acute admittance. Patients with acute appendicitis Blood specimen collection Patients with acute appendicitis, after surgery and with pathohistological specimen confirmation. Patients without acute appendicitis Saliva specimen collection Patients without acute appendicitis, after laboratory, clinical and/or radiological exclusion of acute admittance. Patients with acute appendicitis Saliva specimen collection Patients with acute appendicitis, after surgery and with pathohistological specimen confirmation.
- Primary Outcome Measures
Name Time Method Level of LGR1 protein in blood 72 hours Levels of LGR1 protein in blood and saliva as measured by ELISA test
Level of LGR1 protein saliva 72 hours Levels of LGR1 protein in saliva as measured by ELISA test
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Split
🇭🇷Split, Splitsko-dalmatinska, Croatia